Determination of the arpromidine-type histamine H2-receptor agonist N1-[3-(3,4-difluorophenyl)-3-(2-pyridyl)propyl]-N2-[3-(1H-imidazol-4-yl)propyl]guanidine and corresponding N3-alkoxycarbonylguanidines by HPLC and CE
- 1 March 1997
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 5 (2) , 79-88
- https://doi.org/10.1016/s0928-0987(96)00258-8
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Non-peptide neuropeptide y antagonists derived from the histamine H2 agonist arpromidine: Role of the guanidine groupBioorganic & Medicinal Chemistry Letters, 1995
- BENEFICIAL EFFECT OF H2−AGONISM AND H1−ANTAGONISM IN RAT ENDOTOXIC SHOCKShock, 1994
- KapillarelektrophoresePublished by Springer Nature ,1994
- Capillary Electrophoresis: Principles and PracticePublished by Springer Nature ,1993
- He 90481: A Competitive Nonpeptidergic Antagonist at Neuropeptide Y ReceptorsAnnals of the New York Academy of Sciences, 1990
- Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugsJournal of Medicinal Chemistry, 1989
- Possible value of H2-receptor agonists for treatment of catecholamine-insensitive congestive heart failurePharmacology & Therapeutics, 1984
- Post-column derivatization of guanidino compounds in high-performance liquid chromatography using ninhydrinJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptorsNature, 1978
- Green Fluorescence of Guanidinium Compounds with NinhydrinNature, 1959